Definition and diagnostic criteria of clinical obesity
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
The Global Syndemic of Modifiable Cardiovascular Risk Factors Projected From 2025 to 2050
Obesity and its management in primary care setting
Glucagon-like peptide-1 receptor agonist in myocardial infarction and atherosclerotic cardiovascular disease risk reduction: a comprehensive meta-analysis of number needed to treat, efficacy and safety
Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the <scp>TRIUMPH</scp> registrational clinical trials
GLP‐1 and GIP Beyond Glycaemia: Evolutionary Roles in Energy Optimisation and Organ Protection
Tirzepatide for Obesity Treatment and Diabetes Prevention
Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease
Cardiovascular-Liver-Metabolic Health: Recommendations in Screening, Diagnosis, and Management of Metabolic Dysfunction-Associated Steatotic Liver Disease in Cardiovascular Disease via Modified Delphi Approach
Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial
Efficacy and safety of tirzepatide, <scp>GLP</scp>‐1 receptor agonists, and other weight loss drugs in overweight and obesity: a network meta‐analysis
Subclassification of obesity for precision prediction of cardiometabolic diseases
International consensus position statement on the role of obesity management medications in the context of metabolic bariatric surgery: expert guideline by the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)
Resmetirom and Metabolic Dysfunction-Associated Steatohepatitis: Perspectives on Multidisciplinary Management from Global Healthcare Professionals
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Trends and predictions of malnutrition and obesity in 204 countries and territories: an analysis of the Global Burden of Disease Study 2019
Lancet Diabetes & Endocrinology Commission on the Definition and Diagnosis of Clinical Obesity
Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison
Chronic Semaglutide Treatment in Rats Leads to Daily Excessive Concentration-Dependent Sucrose Intake
Tirzepatide for the treatment of obesity: Rationale and design of the <scp>SURMOUNT</scp> clinical development program
Accurate liquid biopsy for the diagnosis of non-alcoholic steatohepatitis and liver fibrosis
The efficacy of <scp>GLP‐1RAs</scp> for the management of postprandial hypoglycemia following bariatric surgery: a systematic review
Food Intake Following Gastric Bypass Surgery: Patients Eat Less but Do Not Eat Differently
Upper gut heat shock proteins HSP70 and GRP78 promote insulin resistance, hyperglycemia, and non-alcoholic steatohepatitis
Obstacles and Opportunities in Managing Coexisting Obesity and CKD: Report of a Scientific Workshop Cosponsored by the National Kidney Foundation and The Obesity Society
Oromotor and somatic taste reactivity during sucrose meals reveals internal state and stimulus palatability after gastric bypass in rats
Consensus Report: Definition and Interpretation of Remission in Type 2 Diabetes
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Surgery · Physiology →